12.07.2015 Views

STRATEGIC PLAN - ASPE - U.S. Department of Health and Human ...

STRATEGIC PLAN - ASPE - U.S. Department of Health and Human ...

STRATEGIC PLAN - ASPE - U.S. Department of Health and Human ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CHAPTER 2: <strong>Health</strong> careFDA has initiated the Critical Path to PersonalizedMedicine, a program designed to modernize <strong>and</strong> ensuremore efficient development <strong>and</strong> clinical use <strong>of</strong> medicalproducts. Under the Critical Path Initiative, HHSanticipates being able to dramatically increase the successrate in providing patients with innovative solutions thatstrike an optimal balance <strong>of</strong> high benefit <strong>and</strong> low riskbecause they are “personalized.” Once both the disease<strong>and</strong> the person are understood at the molecular level,physicians will be able to provide treatment optionsuniquely suited to a patient’s particular needs.Electronic <strong>Health</strong> RecordsPatients cannot receive appropriate <strong>and</strong> efficient careunless clinical information about them is available at thepoint <strong>of</strong> care. When patients’ health information is notaccessible to providers as they transition through thecontinuum <strong>of</strong> care, clinical decisions <strong>of</strong>ten must be madewithout full knowledge <strong>of</strong> patients’ history <strong>and</strong> healthstatus. The absence <strong>of</strong> needed clinical information canlead to a requirement to duplicate tests that not onlyincrease the costs <strong>of</strong> health care, but also subject patientsto unneeded clinical interventions that always carry adegree <strong>of</strong> risk. Similarly, the absence <strong>of</strong> needed informationcould lead to incorrect decisions or medical errors thatcould result in adverse clinical outcomes. Over time, moreadvanced electronic health records will have integratedclinical decision support with the latest scientific evidenceguiding clinical interventions at the point <strong>of</strong> care alongwith environmental data that should also influencemany treatment decisions. Increasing the adoption <strong>of</strong>interoperable electronic health records will decreasethese risks to both the efficiency <strong>and</strong> efficacy <strong>of</strong> care.Through the collaborative activities <strong>of</strong> the American <strong>Health</strong>Information Community, chaired by the Secretary <strong>of</strong> HHS,much work is underway to identify the functionality <strong>and</strong>st<strong>and</strong>ards that will support the development <strong>and</strong> adoption<strong>of</strong> interoperable electronic health records to achieve thePresident’s vision <strong>of</strong> making electronic health recordsavailable to most Americans by 2014.More information about this effort can be foundlater in this chapter in In the Spotlight: Advancing theDevelopment <strong>and</strong> Use <strong>of</strong> <strong>Health</strong> Information Technology.HHS Strategic Plan FY 2007-201241

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!